BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22026333)

  • 21. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttransplantation lymphoproliferative disorder in a renal allograft recipient.
    Goral S; Felgar R; Shappell S
    Am J Kidney Dis; 1997 Aug; 30(2):301-7. PubMed ID: 9261047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal involvement by post-transplant lymphoproliferative disorders: a review of 81 cases.
    Khedmat H; Amini M; Ghamar-Chehreh ME
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):597-604. PubMed ID: 24821158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus infection has no significant role on lymphoproliferative disorders post liver transplantation: PTLD. int survey.
    Izadi M; Taheri S
    Ann Hepatol; 2011; 10(3):315-20. PubMed ID: 21677333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
    Caillard S; Porcher R; Provot F; Dantal J; Choquet S; Durrbach A; Morelon E; Moal V; Janbon B; Alamartine E; Pouteil Noble C; Morel D; Kamar N; Buchler M; Mamzer MF; Peraldi MN; Hiesse C; Renoult E; Toupance O; Rerolle JP; Delmas S; Lang P; Lebranchu Y; Heng AE; Rebibou JM; Mousson C; Glotz D; Rivalan J; Thierry A; Etienne I; Moal MC; Albano L; Subra JF; Ouali N; Westeel PF; Delahousse M; Genin R; Hurault de Ligny B; Moulin B
    J Clin Oncol; 2013 Apr; 31(10):1302-9. PubMed ID: 23423742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
    Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlough A; Samimagham HR; Azmandian J; Razeghi E; Shahbazian H
    Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.
    Taylor E; Jones M; Hourigan MJ; Johnson DW; Gill DS; Isbel N; Hawley CM; Marlton P; Gandhi MK; Campbell SB; Mollee P
    Nephrol Dial Transplant; 2015 Oct; 30(10):1774-9. PubMed ID: 26188340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
    Khedmat H; Taheri S
    Ann Transplant; 2009; 14(4):80-5. PubMed ID: 20009160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: the PTLD.Int Survey.
    Khedmat H; Taheri S
    Hematol Oncol Stem Cell Ther; 2011; 4(1):10-6. PubMed ID: 21460602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys.
    Schmidtko J; Wang R; Wu CL; Mauiyyedi S; Harris NL; Della Pelle P; Brousaides N; Zagachin L; Ferry JA; Wang F; Kawai T; Sachs DH; Cosimi BA; Colvin RB
    Transplantation; 2002 May; 73(9):1431-9. PubMed ID: 12023621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra-early onset post-transplantation lymphoproliferative disease.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1144-52. PubMed ID: 24231475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T; Zwick DL; Rothberg PG; Warady BA
    Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD20 antigen expression by lymphoma cells in lung allograft recipients is associated with higher remission rate and superior survival: a study on heart and lung transplant recipients.
    Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):29-37. PubMed ID: 24434379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
    Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ
    J Heart Lung Transplant; 2015 Nov; 34(11):1406-14. PubMed ID: 26279197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.
    Libertiny G; Watson CJ; Gray DW; Welsh KI; Morris PJ
    Br J Surg; 2001 Oct; 88(10):1330-4. PubMed ID: 11578286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center.
    Cockfield SM; Preiksaitis JK; Jewell LD; Parfrey NA
    Transplantation; 1993 Jul; 56(1):88-96. PubMed ID: 8333073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression.
    Caillard S; Dharnidharka V; Agodoa L; Bohen E; Abbott K
    Transplantation; 2005 Nov; 80(9):1233-43. PubMed ID: 16314791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
    Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.